Analyst Ratings for Kura Oncology (KURA) [Neutrals]
KURA Rating Summary
KURA Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$30.89 (+64.7%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$30.89 (+64.7%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/27/2023 | Scotiabank » Updated 1/31/2024 |
George Farmer | New Coverage | Sector Perform (N/A) |
22.00 (10.50) |
9.92 (18.75) |
89.01% | Details |
| 11/5/2020 | Piper Sandler | Tyler Van Buren | Downgrade | Neutral (Overweight) |
34.00 (25.00) |
32.76 (18.75) |
-42.77% | Details |
